Azithromycin Inhibits Mucus Hypersecretion from Airway Epithelial Cells
To examine the in vivo effects of the 15-member macrolide, azithromycin (AZM), on mucus hypersecretion, we induced hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium by intranasal instillation of ovalbumin (OVA) in OVA-sensitized rats, or by intranasal lipopolysaccharides (...
Saved in:
Main Authors: | Takeshi Shimizu, Shino Shimizu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2012/265714 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPARγ as a Potential Target to Treat Airway Mucus Hypersecretion in Chronic Airway Inflammatory Diseases
by: Yongchun Shen, et al.
Published: (2012-01-01) -
Chitooligosaccharides suppress airway inflammation, fibrosis, and mucus hypersecretion in a house dust mite-induced allergy model
by: Yun-Ho Kim, et al.
Published: (2025-01-01) -
Novel insights into the study of goblet cell hypersecretion in allergic rhinitis
by: Xiaojia Zhu, et al.
Published: (2025-01-01) -
The Contribution of the Airway Epithelial Cell to Host Defense
by: Frauke Stanke
Published: (2015-01-01) -
Optimization of chemical transfection in airway epithelial cell lines
by: Tony J. F. Guo, et al.
Published: (2025-01-01)